Please seek medical advice to assure yourself that the Aerobika OPEP device is definitely right for you.
Aerobika* Oscillating Positive Expiratory Pressure Therapy System (This Item is GST FREE)
Have you experienced a COPD exacerbation (flare-up)? Acute flare-ups are the most common reason for medical visits, hospital admissions, and deaths in patients with COPD.(1) After a COPD flare-up your lungs may be weakened putting you at risk of another. In fact, 1 in 5 patients hospitalized for a COPD flare-up require re-hospitalization within 30 days. (2)
It's time to break the COPD flare-up cycle. The drug-free Aerobika* device can help.
Using the Aerobika* device in addition to usual COPD treatment after a flare-up has been shown to reduce hospital re-admittance by 28% in the first 30 days after flare-up.(3) It is drug-free and easy-to-use with no side-effects or drug interactions.
In a patient satisfaction survey, 97% of respondents said they would continue to use the Aerobika* device.†4
†Patient satisfaction survey given to 504 patients after ≥3 weeks of twice-daily use of the Aerobika* device.
1 O’Donnell DE, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2007 update. Can Respir J. 2007;14(Suppl B):5B-32B.
2 Shah T, et al. COPD Readmissions: Addressing COPD in the Era of Value-Based Healthcare. Chest. 2016 May 7. doi: 10.1016/j.chest.2016.05.002. [Epub ahead of print]
3 Burudpakdee C, et al. A Real World Study of Aerobika* OPEP in Chronic Obstructive Pulmonary Disease Patients, Investigating Hospital Related Exacerbations. Manuscript.
4 Harkness H, et al. Survey of Patients Using an Oscillating Positive Expiratory Pressure Device Indicates Improvement in Well-Being and Compliance to Therapy. Presented at: Canadian Respiratory Conference. April 23–25, 2015. Ottawa, Ontario.
5 S Svenningsen et al. Presented at ERS 2014.
6 World Health Organization, Fact sheet N°310 Updated May 2014